Research and Markets: Epilepsy Pipeline Highlights - 2014 Update

Business Wire


Research and Markets ( has announced the addition of the "Epilepsy Pipeline Highlights - 2014 Update" report to their offering.

The latest report Epilepsy Pipeline Highlights - 2014 Update, provides most up-to-date information on key pipeline molecules in the global Epilepsy market. It covers emerging therapies for Epilepsy in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Epilepsy pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Epilepsy pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.


The report provides Epilepsy pipeline molecules by the Originator Company.

Short-term Launch Highlights:

Find out which Epilepsy pipeline products will be launched in the US and Ex-US till 2017.

Key Topics Covered:

1. Epilepsy Pipeline by Stages

2. Epilepsy Pipeline by Drug Class

3. Epilepsy Pipeline by Company

4. Epilepsy Phase 3 Clinical Trial Insights

5. Epilepsy Phase 2 Clinical Trial Insights

6. Epilepsy Phase 1 Clinical Trial Insights

7. Epilepsy Preclinical Research Insights

8. Epilepsy Discovery Stage Insights

9. Appendix

10. Research Methodology

For more information visit

Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals
View Comments (0)